DK5089A - 2-substituerede adenosinderivater - Google Patents

2-substituerede adenosinderivater

Info

Publication number
DK5089A
DK5089A DK005089A DK5089A DK5089A DK 5089 A DK5089 A DK 5089A DK 005089 A DK005089 A DK 005089A DK 5089 A DK5089 A DK 5089A DK 5089 A DK5089 A DK 5089A
Authority
DK
Denmark
Prior art keywords
substituted
adenosin
derivatives
adenosin derivatives
substituted adenosin
Prior art date
Application number
DK005089A
Other languages
Danish (da)
English (en)
Other versions
DK5089D0 (da
Inventor
Alan J Hutchison
John E Francis
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK5089D0 publication Critical patent/DK5089D0/da
Publication of DK5089A publication Critical patent/DK5089A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK005089A 1988-01-07 1989-01-06 2-substituerede adenosinderivater DK5089A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14205588A 1988-01-07 1988-01-07
US07/193,968 US5034381A (en) 1988-01-07 1988-05-13 2-(substituted amino) adenosines as antihypertensives

Publications (2)

Publication Number Publication Date
DK5089D0 DK5089D0 (da) 1989-01-06
DK5089A true DK5089A (da) 1989-07-08

Family

ID=26839719

Family Applications (1)

Application Number Title Priority Date Filing Date
DK005089A DK5089A (da) 1988-01-07 1989-01-06 2-substituerede adenosinderivater

Country Status (17)

Country Link
US (1) US5034381A (fr)
EP (1) EP0323807A3 (fr)
JP (1) JPH01265100A (fr)
KR (1) KR890011903A (fr)
AU (1) AU618055B2 (fr)
CA (1) CA1325209C (fr)
DD (1) DD283402A5 (fr)
DK (1) DK5089A (fr)
FI (1) FI90430C (fr)
HU (1) HU202550B (fr)
IL (1) IL88877A0 (fr)
MX (1) MX14446A (fr)
NO (1) NO169843C (fr)
NZ (1) NZ227542A (fr)
PH (1) PH26672A (fr)
PT (1) PT89392B (fr)
ZA (1) ZA8984B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3820989A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives
US4977144A (en) * 1988-08-02 1990-12-11 Ciba-Geigy Corporation Imidazo[4,5-b]pyridine derivatives as cardiovascular agents
US5189027A (en) 1990-11-30 1993-02-23 Yamasa Shoyu Kabushiki Kaisha 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases
US5206222A (en) * 1991-05-22 1993-04-27 Vanderbilt University Methods for the reduction of myocardial reperfusion injury
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
IL107101A0 (en) * 1992-09-30 1993-12-28 Merrell Dow Pharma 2-substituted adenosines with a-2 receptor affinity
US5426101A (en) * 1992-09-30 1995-06-20 Merrell Dow Pharmaceuticals Inc. 2-substituted adenosines with A-2 receptor affinity
WO1994023723A1 (fr) * 1993-04-15 1994-10-27 New York University Agonistes de recepteur de l'adenosine favorisant la cicatrisation des lesions
US5817641A (en) * 1994-07-21 1998-10-06 Thomas Jefferson University Treatment of enterotoxigenic diarrhea with 2-substituted adenosine derivatives
WO1998057651A1 (fr) 1997-06-18 1998-12-23 Discovery Therapeutics, Inc. Compositions et procedes prevenant les restenoses consecutives a des interventions de revascularisation
WO1999017784A1 (fr) 1997-10-07 1999-04-15 Regents Of The University Of California Corporation Traitement de la vasculopathie peripherique obliterante et de la coronarite au moyen de conbinaisons d'heparine et d'un agoniste a2 adenosine, ou au moyen d'adenosine
US5972903A (en) * 1997-10-07 1999-10-26 Regents Of The University Of California Corporation Method for promoting angiogenesis using heparin and adenosine
CN1181087C (zh) * 1998-07-09 2004-12-22 三共株式会社 新的抗菌化合物
AU4343500A (en) 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
WO2006089053A2 (fr) 2005-02-17 2006-08-24 Wyeth Derive d'indole, benzothiophene, benzofurane et indene a fusion cycloalkyle
US20090136460A1 (en) * 2007-07-10 2009-05-28 Vanderbilt University Use of adenosine receptor ligands to promote cell adhesion in cell-based therapies
RU2695358C2 (ru) * 2013-10-23 2019-07-23 Академия Синика Соединения для предотвращения и лечения нейродегенеративных заболеваний и боли

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670265A1 (de) * 1967-08-25 1971-01-28 Boehringer Mannheim Gmbh 2-Amino-Adenosinderivate und Verfahren zu deren Herstellung
NL7203984A (fr) * 1971-04-10 1972-10-12
US3917583A (en) * 1972-08-04 1975-11-04 Icn Pharmaceuticals 2-Substituted cyclic AMP derivatives
AR205247A1 (es) * 1973-02-07 1976-04-21 Icn Pharmaceuticals Procedimiento para preparar derivados de amp 2-substituidos
JPS5630355B2 (fr) * 1974-01-21 1981-07-14
AU5118979A (en) * 1978-10-16 1980-04-24 Takeda Chemical Industries Ltd. 2,6-diaminoebularines
JPS55139399A (en) * 1979-04-12 1980-10-31 Asahi Chem Ind Co Ltd Novel adenosine derivative substituted in the 2-position
JPS56152437U (fr) * 1980-04-14 1981-11-14
US4501735A (en) * 1983-12-05 1985-02-26 Warner-Lambert Company N6-(1- and 2-benzocycloalkyl) adenosines
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
ATE50777T1 (de) * 1984-04-18 1990-03-15 Whitby Research Inc Cardio-vasodilatatore n-6-substituierte adenosine.
US4594350A (en) * 1984-07-30 1986-06-10 Reagents Of University Of Minnesota (3-ethoxypropionate) esters of cyclaradine
US4683223A (en) * 1985-09-09 1987-07-28 Warner-Lambert Company N6 -Benzopyrano-and benzothiopyrano adenosines and methods of use
US4791103A (en) * 1985-02-08 1988-12-13 Warner-Lambert Company 2,N6 -disubstituted adenosines, derivatives and methods of use
US4593019A (en) * 1984-10-26 1986-06-03 Warner-Lambert Company N6 -tricyclic adenosines
US4600707A (en) * 1985-01-25 1986-07-15 Warner-Lambert Company Benzothien-3-yl adenosine; benzothien-3-yl adenosine, S-oxide; and benzothien-3-yl, S,S-dioxide adenosine compounds
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
US4843066A (en) * 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
EP0277917A3 (fr) * 1987-02-04 1990-03-28 Ciba-Geigy Ag Certains dérivés d'adénosine-5'-carboxamide

Also Published As

Publication number Publication date
ZA8984B (en) 1989-08-30
FI890028A (fi) 1989-07-08
DK5089D0 (da) 1989-01-06
HU202550B (en) 1991-03-28
EP0323807A2 (fr) 1989-07-12
EP0323807A3 (fr) 1990-06-20
FI890028A0 (fi) 1989-01-04
IL88877A0 (en) 1989-08-15
NO885821D0 (no) 1988-12-30
MX14446A (es) 1994-01-31
KR890011903A (ko) 1989-08-23
PH26672A (en) 1992-09-15
AU618055B2 (en) 1991-12-12
NO169843C (no) 1992-08-12
PT89392B (pt) 1993-09-30
DD283402A5 (de) 1990-10-10
NO885821L (no) 1989-07-10
NZ227542A (en) 1992-03-26
PT89392A (pt) 1990-02-08
NO169843B (no) 1992-05-04
US5034381A (en) 1991-07-23
HUT48904A (en) 1989-07-28
CA1325209C (fr) 1993-12-14
AU2776789A (en) 1989-07-13
FI90430C (fi) 1994-02-10
FI90430B (fi) 1993-10-29
JPH01265100A (ja) 1989-10-23

Similar Documents

Publication Publication Date Title
TR26815A (tr) Azolilmetil-sikropil türevleri
DE68925405D1 (de) Carbostyril-Derivate
KR900700424A (ko) 디플루오로벤젠 유도체
DE68925161D1 (de) Alkylavermectin-Derivate
DE68927948D1 (de) Trehalosderivate
DK5089A (da) 2-substituerede adenosinderivater
DK391189D0 (da) Carbostyrilderivater
DK19789D0 (da) Dehydrocholcalciferolderivater
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
DK507188A (da) Cholecalciferolderivater
DE68927657D1 (de) Butynylaminderivate
DK378088D0 (da) Alkenderivater
DK486089D0 (da) Pyranobenzoxadiazolderivater
DK49688D0 (da) Propiolophenonderivater
DK82189D0 (da) Substituerede quinolinderivater
DK81989A (da) Substituerede quinolinderivater
DK160389A (da) Aryldionderivater
DK271088D0 (da) Tienopyridinderivater
DK339189D0 (da) Purinderivater
ATA155589A (de) Mitomycinphosphat-derivate
DK695788D0 (da) Naphtalenderivater
DE68927179D1 (de) Carbostyril-derivate
DK324489D0 (da) Substituerede azacyclohexylderivater
DK82089A (da) Substituerede quinolinderivater
DK733688A (da) Dioxazocinderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment